Anteris Technologies Global Corp.

NASDAQ:AVR

Medical - Devices

Healthcare
$5.21 -0.16%

-$0.02 today

Market cap
$507.94M
Beta
0.73
P/E (TTM)
-2.3
EPS (TTM)
-$4.04
52W Low $2.85High $10.14

Volume 1.24M

Average 1.18M

AVR Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Anteris Technologies Global Corp.NASDAQ: AVR

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit turns negative

Q1 FY2026 gross profit was -$49K, compared with $349K a year earlier. Trailing-twelve-month gross profit was $523K.

Context

  • Gross profit amounted to 16.6% of revenue in FY2025, down 30.3 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near -$49K or moves back toward the trailing-twelve-month quarterly average of $130.75K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$49K+76.0% QoQ
Last fiscal yearDec 2025
-$317K-125.0% YoY
LTMMar 2026
$523K-60.4% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-114.0%——
1 year-125.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
(317K) USD
Year-over-year change
-125.0%

Gross Profit vs competitors

How AVR compares with its peers on the latest reported figures

  • AVR's LTM Mar 2026 gross profit of $523K is the lowest of the 6 companies compared; the peer median is $5.08B.
  • Its year-over-year change of -60.4% is the lowest of 6, against a peer median of +15.4%.
  • Gross profit amounts to 28.3% of revenue for AVR, versus a peer median of 67.9%.
AVR Competitors Peer median
Gross Profit for AVR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$25.04B +15.4%+4.9%66.7%
BSXBoston Scientific CorporationLTM Jun 2026$14.94B +27.8%+21.5%71.2%
EWEdwards Lifesciences CorporationLTM Jun 2026$5.08B +13.2%+4.0%78.0%
LIVNLivaNova PLCLTM Sep 2026$1.02B +10.7%+9.9%67.9%
AORTArtivion, Inc.LTM Mar 2026$288.7M +15.8%+10.1%62.9%
AVRAnteris Technologies Global Corp.LTM Mar 2026$523K -60.4%—28.3%
Peer median (excluding AVR) $5.08B+15.4%+9.9%67.9%

Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.83M3.2M2.73M2.7M1.91M
Cost of Revenue3.93M2.9M1.86M1.44M2.23M
Gross Profit1.91M298.38K876.8K1.27M(317K)
Gross Margin32.7%9.3%32.1%46.8%-16.6%
Research & Development9.99M17.59M31.02M51.45M69.12M
Selling, General & Admin9.14M15.21M17.05M024.46M
Operating Expenses18.77M31.41M49.02M79.64M93.58M
Depreciation & Amortization640.09K774.08K1.16M1.51M1.66M
EBITDA(15.5M)(29.14M)(45.54M)(74.38M)(92.49M)
EBITDA Margin-265.8%-910.5%-1665.1%-2751.7%-4834.9%
Operating Income(16.86M)(31.11M)(48.14M)(78.37M)(93.89M)
Operating Margin-289.2%-972.1%-1760.3%-2899.4%-4908.2%
Interest Income68.55K210.38K428.06K0709K
Interest Expense1.03M648.71K67.09K82K73K
Other Income / Expenses(310.48K)550.48K1.38M2.41M(331K)
Income Before Tax(17.17M)(30.56M)(46.76M)(75.97M)(94.23M)
Pre-Tax Margin-294.5%-954.9%-1709.9%-2810.5%-4925.5%
Income Tax Expense00000
Net Income(17.17M)(30.56M)(46.02M)(76.29M)(94.14M)
Net Margin-294.5%-954.9%-1682.8%-2822.5%-4921.3%
EPS (Basic)(0.48)(0.85)(1.28)(3.77)(4.00)
EPS (Diluted)(0.48)(0.85)(1.28)(3.77)(4.00)
Weighted Avg Shares35.94M35.94M35.94M20.25M23.58M
Weighted Avg Shares (Diluted)35.94M35.94M35.94M20.25M23.58M

Anteris Technologies Global Corp.

NASDAQ:AVR

Intrinsic Alpha fair value

Locked

Current Price

$5.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.